Incon

(주)인콘 · KOSDAQ · 083640 · Industry: Non-specialized wholesale trade

Key metrics

Earnings

Revenue, Q3 2026₩5.3bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ-44.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY-35.0% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩775m As of Sep 30, 2026 Source 1 ↗
Operating income QoQ-68.4% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-318.6% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩15.0bn As of May 14, 2026 Source 1 ↗
Rights offering new shares, last 12 months7,414,273 shares As of Jun 23, 2026 Source 1 ↗
Potential new shares, last 12 months10,378,699 shares As of Jun 23, 2026 Source 1 ↗, Source 2 ↗
Potential new shares, % of shares66.8% As of Jun 23, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩11.3bn As of Nov 9, 2026 Source 1 ↗, Source 2
Supply contracts vs prior-year revenue22.3% As of Nov 9, 2026 Source 1 ↗, Source 2
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months13 As of Nov 19, 2026
DART filings, previous 3 months19 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Aug 25, 2026MiraeING.Co.LTD (Controlling shareholder)Other (Reverse split)-5,931,419 shares——
Aug 25, 2026KBIO LABS Inc. (10%+ shareholder)Other (Reverse split)-4,253,996 shares——
Jul 3, 2026MiraeING.Co.LTD (Controlling shareholder)Other (Paid-in new shares)+7,414,273 shares——
Jul 3, 2026KBIO LABS Inc. (10%+ shareholder)Other (Other increase)0 shares——
Apr 16, 2026KBIO LABS Inc. (10%+ shareholder)Other (Reverse split)-21,269,979 shares——

Annual financials

YearRevenueOperating income
2025₩50.8bn₩1.7bn
2024₩49.1bn₩1.6bn
2023₩63.4bn₩2.6bn

Filing timeline